SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

TESTA, Maria Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 371
AS - Asia 107
EU - Europa 97
AF - Africa 2
Totale 577
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 368
IT - Italia 46
SG - Singapore 35
CN - Cina 33
ID - Indonesia 18
DE - Germania 13
CZ - Repubblica Ceca 9
IQ - Iraq 7
SE - Svezia 6
TR - Turchia 6
FI - Finlandia 5
FR - Francia 4
HK - Hong Kong 4
RU - Federazione Russa 4
UA - Ucraina 4
CA - Canada 3
NG - Nigeria 2
NL - Olanda 2
TW - Taiwan 2
BE - Belgio 1
CH - Svizzera 1
GB - Regno Unito 1
IN - India 1
JP - Giappone 1
NO - Norvegia 1
Totale 577
Salva come PNG Salva come JPEG
Città #
Fairfield 50
Chandler 48
Singapore 28
Ferrara 27
New York 26
Ashburn 22
Seattle 22
Jakarta 18
Wilmington 18
Houston 16
Cambridge 15
Woodbridge 14
Shanghai 12
Princeton 10
Brno 8
San Diego 8
Baghdad 7
Bremen 7
Los Angeles 7
Milan 7
Izmir 6
Dearborn 5
Redwood City 5
Bologna 4
Helsinki 4
Jacksonville 4
Rochester 4
San Mateo 4
Santa Clara 4
Kunming 3
Nanjing 3
Ann Arbor 2
Beijing 2
Florence 2
Henderson 2
Hong Kong 2
Jiaxing 2
Lagos 2
Monmouth Junction 2
Moscow 2
Munich 2
Noventa Vicentina 2
Padova 2
Shenyang 2
Taipei 2
The Hague 2
Toronto 2
Worcester 2
Andover 1
Boardman 1
Brussels 1
Central District 1
Changsha 1
Dallas 1
Ferrara di Monte Baldo 1
Guangzhou 1
Jinan 1
Kanpur 1
Kowloon City 1
Lappeenranta 1
Leawood 1
London 1
Mountain View 1
Mégevette 1
Nanchang 1
Norwalk 1
Olomouc 1
Orange 1
Oslo 1
Ottawa 1
Piemonte 1
Sayreville 1
Tokyo 1
Washington 1
Totale 476
Salva come PNG Salva come JPEG
Nome #
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 102
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 92
TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes 78
Exploring spontaneous readthrough over recurrent F8 nonsense mutations: potential correlation with inhibitor risk? 49
Molecular insights into determinants of translational readthrough and implications for nonsense suppression approaches 42
Translation termination codons in protein synthesis and disease 41
Detection of Residual Factor VIII Levels Reveals the Occurrence of Readthrough Over the Majority of F8 Nonsense Mutations 41
An advanced method for the small-scale production of high-quality minicircle DNA 36
Spontaneous readthrough over recurrent F8 nonsense mutations is associated with residual factor VIII levels: implications for inhibitor risk? 32
Comparative Analysis Of Residual Factor VIII Expression from Recurrent F8 Nonsense Mutations Indicates that Localization in the B- domain Favours Readthrough- mediated Protein Output 24
Translational readthrough at F8 nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor association 24
A factor X variant with engineered activation peptide as innovative by-passing agent for haemophilia 19
An engineered factor X variant as a novel by-passing agent for hemophilia 18
The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms 14
Engineered suppressor tRNAs as a novel correction approach for recurrent hemophilia A-causing nonsense mutations 8
An integrated multi-tool analysis contributes elements to interpreting unclassified factor IX missense variants associated with haemophilia B 7
Totale 627
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 237
Totale 4.978
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202074 0 0 0 10 6 13 16 12 9 4 1 3
2020/202170 4 4 1 3 1 5 18 14 3 4 12 1
2021/202280 17 7 1 6 1 3 1 2 4 7 3 28
2022/2023115 11 14 5 9 16 8 11 11 14 2 4 10
2023/2024128 6 6 7 1 4 33 4 10 10 4 5 38
2024/202583 23 8 47 5 0 0 0 0 0 0 0 0
Totale 627